Author

J. McCafferty

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Bioengineering· 1 Immunology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Assay:bulk RNA-seq· 1 Research Focus:cell type annotation· 1 Research Focus:host-pathogen & immune response· 1 Organism:human· 1 Organism:mouse· 1

Frequent Co-Authors

A. Karatt-Vellatt· 2 shared L. Ledsgaard· 2 shared P. Villar· 2 shared A. H. Laustsen· 1 shared B. Lomonte· 1 shared C. Tebbutt· 1 shared D. Matthews· 1 shared D. Pazeraitis· 1 shared

Activity by Year

2020-2022 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 35 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersBioengineering

A. Karatt-Vellatt

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Discovery of a broadly-neutralizing human antibody that can rescue mice challenged with neurotoxin-rich snake venoms

L. Ledsgaard, J. Wade, K. Boddum, I. Oganesyan, J. Harrison, T. P. Jenkins, P. Villar, R. A. Leah, R. Zenobi, J. McCafferty, B. Lomonte, J. M. Gutierrez, A. H. Laustsen, A. Karatt-Vellatt

This paper describes the discovery of a broadly-neutralizing human antibody effective against multiple snake venoms, demonstrating its therapeutic potential in mice.

bioRxiv · Jun 17, 2022 · PreprintBioengineering

Deep mining of early antibody response in COVID-19 patients yields potent neutralisers and reveals high level of convergence

G. Bullen, J. D. Galson, P. Villar, L. Moreels, L. Ledsgaard, G. Mattiuzzo, G. Hall, E. M. Bentley, E. W. Masters, D. Tang, S. Millett, D. Tongue, R. Brown, I. Diamantopoulos, K. Parthiban, , A. Karatt-Vellatt

The paper identifies potent neutralising antibodies from early COVID-19 patient samples and shows high convergence in antibody sequences across studies.

bioRxiv · Dec 29, 2020 · PreprintImmunology